Type 1 Facioscapulohumeral Muscular Dystrophy clinical trials

Explore recruiting type 1 facioscapulohumeral muscular dystrophy clinical trials.

Recruiting type 1 facioscapulohumeral muscular dystrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 1 Facioscapulohumeral Muscular Dystrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A bicentric, randomized, double blind, placebo-controlled pilot study to evaluate the efficacy and safety of satralizumab in FSHD1

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Type 1 Facioscapulohumeral Muscular Dystrophy trials by city

Type 1 Facioscapulohumeral Muscular Dystrophy in Toronto Type 1 Facioscapulohumeral Muscular Dystrophy in Vancouver Type 1 Facioscapulohumeral Muscular Dystrophy in Montreal Type 1 Facioscapulohumeral Muscular Dystrophy in Calgary Type 1 Facioscapulohumeral Muscular Dystrophy in Edmonton Type 1 Facioscapulohumeral Muscular Dystrophy in Ottawa Type 1 Facioscapulohumeral Muscular Dystrophy in Winnipeg Type 1 Facioscapulohumeral Muscular Dystrophy in Quebec City Type 1 Facioscapulohumeral Muscular Dystrophy in Hamilton Type 1 Facioscapulohumeral Muscular Dystrophy in Kitchener Type 1 Facioscapulohumeral Muscular Dystrophy in London Type 1 Facioscapulohumeral Muscular Dystrophy in Halifax Type 1 Facioscapulohumeral Muscular Dystrophy in New York Type 1 Facioscapulohumeral Muscular Dystrophy in Los Angeles Type 1 Facioscapulohumeral Muscular Dystrophy in Chicago Type 1 Facioscapulohumeral Muscular Dystrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease